Streamline Health Solutions, Inc. (STRM)
Aug 12, 2025 - STRM was delisted (reason: acquired by MDaudit)
5.33
0.00 (-0.06%)
Inactive · Last trade price on Aug 11, 2025
STRM Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for STRM in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for STRM.
Recommendation Trends
| Rating | Jul '22 | Aug '22 | Sep '22 | Oct '22 | Nov '22 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +744.28% | Nov 21, 2022 |
| Lake Street | Lake Street | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +744.28% | May 20, 2022 |
| Lake Street | Lake Street | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 25, 2016 |
| Lake Street | Lake Street | Strong Buy Initiates $150 | Strong Buy | Initiates | $150 | +2,714.26% | Feb 4, 2014 |
Financial Forecast
Revenue This Year
21.24M
from 17.90M
Increased by 18.64%
Revenue Next Year
n/a
from 21.24M
EPS This Year
-0.11
from -2.53
EPS Next Year
n/a
from -0.11
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 |
|---|---|
| High | 21.9M |
| Avg | 21.2M |
| Low | 20.4M |
Revenue Growth
| Revenue Growth | 2026 |
|---|---|
| High | 22.1% |
| Avg | 18.6% |
| Low | 14.0% |
EPS Forecast
| EPS | 2026 |
|---|---|
| High | -0.12 |
| Avg | -0.11 |
| Low | -0.11 |
EPS Growth
| EPS Growth | 2026 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.